AlphaYouMH
Insider selling
Mark Hopman sold $7K of Beta Bionics, Inc. (BBNX) stock
Mark Hopman, Chief Commercial Officer of Beta Bionics, Inc. (BBNX), sold 370 shares of BBNX stock worth $7K, per an SEC Form 4 filed Oct 5, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Oct 1, 2026, 4 days before it was made public.
BBNX has moved +0.5% since the trade date, from $18.87 to $18.96 (Oct 2, 2026 close).
- Traded
- Oct 1, 2026
- Disclosed
- Oct 5, 2026
- Filing delay
- 4 days
- Price since
- +0.5%
- Role
- Chief Commercial Officer
- Source
- SEC Form 4
More BBNX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.